Filing Details
- Accession Number:
- 0001127602-25-014486
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-15 16:41:58
- Reporting Period:
- 2025-05-14
- Filing Date:
- 2025-05-15
- Accepted Time:
- 2025-05-15 16:41:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221496 | George Massaro | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-14 | 91 | $139.95 | 5,764 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-14 | 21 | $140.78 | 5,743 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-14 | 14 | $141.85 | 5,729 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-14 | 7 | $143.77 | 5,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-14 | 7 | $145.54 | 5,715 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $139.47 to $140.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- This transaction was executed in multiple trades at prices ranging from $140.52 to $141.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- This transaction was executed in multiple trades at prices ranging from $141.80 to $141.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- This transaction was executed in multiple trades at prices ranging from $143.70 to $143.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Billionaire Hedge Funds
